Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IntelliSanté was a U.S. digital health company focused on cloud-based, HIPAA-compliant software for chronic care management, patient engagement, and care-team collaboration. Its flagship product, C3HealthLink, functioned as a personal health record and communication platform that allowed patients, caregivers, providers, and payers to share data, monitor health metrics, manage medications, and coordinate care. The company also described additional software assets including C3Interact and C3Knowledge Exchange for enterprise communication and application development. Based on available public sources, IntelliSanté appears to have operated as a healthcare software vendor rather than a drug-development biotech or pharmaceutical company. Public profiles indicate the company is no longer active.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IntelliSanté.